Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

1,098

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

September 30, 2008

Conditions
Hypertension
Interventions
DRUG

fixed dose combination of telmisartan+amlodipine

DRUG

amlodipine

Trial Locations (129)

Unknown

1235.5.32004 Boehringer Ingelheim Investigational Site, Aywaille

1235.5.32001 Boehringer Ingelheim Investigational Site, Brussels

1235.5.32010 Boehringer Ingelheim Investigational Site, Gozée

1235.5.32008 Boehringer Ingelheim Investigational Site, Linkebeek

1235.5.32003 Boehringer Ingelheim Investigational Site, Mol

1235.5.32007 Boehringer Ingelheim Investigational Site, Natoye

1235.5.32009 Boehringer Ingelheim Investigational Site, Tavier

1235.5.32002 Boehringer Ingelheim Investigational Site, Tienen-Kumtich

1235.5.32005 Boehringer Ingelheim Investigational Site, Turnhout

1235.5.20001 Boehringer Ingelheim Investigational Site, Coquitlam

1235.5.20011 Boehringer Ingelheim Investigational Site, Vancouver

1235.5.20007 Boehringer Ingelheim Investigational Site, Bay Roberts

1235.5.20005 Boehringer Ingelheim Investigational Site, Mount Pearl

1235.5.20008 Boehringer Ingelheim Investigational Site, St. John's

1235.5.20013 Boehringer Ingelheim Investigational Site, Corunna

1235.5.20014 Boehringer Ingelheim Investigational Site, Etobicoke

1235.5.20010 Boehringer Ingelheim Investigational Site, Hamilton

1235.5.20012 Boehringer Ingelheim Investigational Site, London

1235.5.20009 Boehringer Ingelheim Investigational Site, Ottawa

1235.5.20006 Boehringer Ingelheim Investigational Site, Sarnia

1235.5.20003 Boehringer Ingelheim Investigational Site, Sainte-Foy

1235.5.45002 Boehringer Ingelheim Investigational Site, Birkerød

1235.5.45005 Boehringer Ingelheim Investigational Site, Haderslev

1235.5.45008 Boehringer Ingelheim Investigational Site, Herning

1235.5.45009 Boehringer Ingelheim Investigational Site, Hinnerup

1235.5.45001 Boehringer Ingelheim Investigational Site, Rødovre Municipality

1235.5.45006 Boehringer Ingelheim Investigational Site, Rødovre Municipality

1235.5.45003 Boehringer Ingelheim Investigational Site, Vaerløse

1235.5.45007 Boehringer Ingelheim Investigational Site, Vildbjerg

1235.5.35003 Boehringer Ingelheim Investigational Site, Joensuu

1235.5.35004 Boehringer Ingelheim Investigational Site, Joensuu

1235.5.35001 Boehringer Ingelheim Investigational Site, Turku

1235.5.35002 Boehringer Ingelheim Investigational Site, Turku

1235.5.3301H Boehringer Ingelheim Investigational Site, Aigrefeuille S/Maine

1235.5.3306C Boehringer Ingelheim Investigational Site, Angers

1235.5.3309B Boehringer Ingelheim Investigational Site, Angers

1235.5.3309C Boehringer Ingelheim Investigational Site, Angers

1235.5.3309E Boehringer Ingelheim Investigational Site, Angers

1235.5.3309D Boehringer Ingelheim Investigational Site, Avrillé

1235.5.3309A Boehringer Ingelheim Investigational Site, Beaucouzé

1235.5.3303B Boehringer Ingelheim Investigational Site, Bono

1235.5.3305A Boehringer Ingelheim Investigational Site, Bourg Des Cptes

1235.5.3306D Boehringer Ingelheim Investigational Site, Briollay

1235.5.3308B Boehringer Ingelheim Investigational Site, Cholet

1235.5.3308C Boehringer Ingelheim Investigational Site, Cholet

1235.5.3308D Boehringer Ingelheim Investigational Site, Cholet

1235.5.3308F Boehringer Ingelheim Investigational Site, Cholet

1235.5.3302C Boehringer Ingelheim Investigational Site, Garchizy

1235.5.3303C Boehringer Ingelheim Investigational Site, Grandchamps

1235.5.3302D Boehringer Ingelheim Investigational Site, Guérigny

1235.5.3310A Boehringer Ingelheim Investigational Site, Jarny

1235.5.3301L Boehringer Ingelheim Investigational Site, La Chapelle /s Erdre

1235.5.3301J Boehringer Ingelheim Investigational Site, La Chapelle-sur-Erdre

1235.5.3304A Boehringer Ingelheim Investigational Site, La Fresnais

1235.5.3308E Boehringer Ingelheim Investigational Site, La Jubaudière

1235.5.3301G Boehringer Ingelheim Investigational Site, La Montagne

1235.5.3307D Boehringer Ingelheim Investigational Site, Le Mesnil-en-Vallée

1235.5.3301E Boehringer Ingelheim Investigational Site, Le Temple-de-Bretagne

1235.5.3309F Boehringer Ingelheim Investigational Site, Les Ponts-de-Cé

1235.5.3307G Boehringer Ingelheim Investigational Site, Loudun

1235.5.3305B Boehringer Ingelheim Investigational Site, Louvigné Le Bais

1235.5.3307E Boehringer Ingelheim Investigational Site, Mouliherne

1235.5.3306A Boehringer Ingelheim Investigational Site, Mûrs-Erigné

1235.5.3307A Boehringer Ingelheim Investigational Site, Mûrs-Erigné

1235.5.3301A Boehringer Ingelheim Investigational Site, Nantes

1235.5.3301B Boehringer Ingelheim Investigational Site, Nantes

1235.5.3301D Boehringer Ingelheim Investigational Site, Nantes

1235.5.3301M Boehringer Ingelheim Investigational Site, Nantes

1235.5.3302A Boehringer Ingelheim Investigational Site, Nevers

1235.5.3302F Boehringer Ingelheim Investigational Site, Nevers

1235.5.3301I Boehringer Ingelheim Investigational Site, Nort-sur-Erdre

1235.5.3301C Boehringer Ingelheim Investigational Site, Orvault

1235.5.3307F Boehringer Ingelheim Investigational Site, Parçay-les-Pins

1235.5.3301F Boehringer Ingelheim Investigational Site, Saint Aubin Les Châteaux

1235.5.3306F Boehringer Ingelheim Investigational Site, Saint-Georges-de-Montaigu

1235.5.3304B Boehringer Ingelheim Investigational Site, Saint-Ouen-la-Rouërie

1235.5.3307C Boehringer Ingelheim Investigational Site, Saint-Pierre-Montlimart

1235.5.3301N Boehringer Ingelheim Investigational Site, Sautron

1235.5.3306B Boehringer Ingelheim Investigational Site, Segré

1235.5.3306E Boehringer Ingelheim Investigational Site, Thouars

1235.5.3304C Boehringer Ingelheim Investigational Site, Tinténiac

1235.5.3303A Boehringer Ingelheim Investigational Site, Vannes

1235.5.3308A Boehringer Ingelheim Investigational Site, Vihiers

1235.5.31008 Boehringer Ingelheim Investigational Site, Beerzerveld

1235.5.31006 Boehringer Ingelheim Investigational Site, Bennebroek

1235.5.31004 Boehringer Ingelheim Investigational Site, Hoogwoud

1235.5.31003 Boehringer Ingelheim Investigational Site, Musselkanaal

1235.5.31007 Boehringer Ingelheim Investigational Site, Nijverdal

1235.5.31001 Boehringer Ingelheim Investigational Site, Oude Pekela

1235.5.31005 Boehringer Ingelheim Investigational Site, Roelofarendsveen

1235.5.31010 Boehringer Ingelheim Investigational Site, Voerendaal

1235.5.47001 Boehringer Ingelheim Investigational Site, Ålesund

1235.5.47002 Boehringer Ingelheim Investigational Site, Bergen

1235.5.47003 Boehringer Ingelheim Investigational Site, Hamar

1235.5.47004 Boehringer Ingelheim Investigational Site, Oslo

1235.5.63006 Boehringer Ingelheim Investigational Site, Makati City

1235.5.63001 Boehringer Ingelheim Investigational Site, Manila

1235.5.63002 Boehringer Ingelheim Investigational Site, Manila

1235.5.63009 Boehringer Ingelheim Investigational Site, Manila

1235.5.63008 Boehringer Ingelheim Investigational Site, Pasay

1235.5.63005 Boehringer Ingelheim Investigational Site, Pasig

1235.5.63003 Boehringer Ingelheim Investigational Site, Quezon City

1235.5.63007 Boehringer Ingelheim Investigational Site, Quezon City

1235.5.27003 Boehringer Ingelheim Investigational Site, Boksburg

1235.5.27006 Boehringer Ingelheim Investigational Site, Cape Town

1235.5.27009 Boehringer Ingelheim Investigational Site, Cape Town

1235.5.27010 Boehringer Ingelheim Investigational Site, Cape Town

1235.5.27004 Boehringer Ingelheim Investigational Site, Durban

1235.5.27008 Boehringer Ingelheim Investigational Site, Johannesburg

1235.5.27001 Boehringer Ingelheim Investigational Site, Krugersdorp

1235.5.27005 Boehringer Ingelheim Investigational Site, Lenasia

1235.5.27002 Boehringer Ingelheim Investigational Site, Pretoria

1235.5.82007 Boehringer Ingelheim Investigational Site, Busan

1235.5.82001 Boehringer Ingelheim Investigational Site, Daegu

1235.5.82006 Boehringer Ingelheim Investigational Site, Daejeon

1235.5.82004 Boehringer Ingelheim Investigational Site, Gangwon-Do

1235.5.82008 Boehringer Ingelheim Investigational Site, Gwangju

1235.5.82002 Boehringer Ingelheim Investigational Site, Seoul

1235.5.82003 Boehringer Ingelheim Investigational Site, Seoul

1235.5.82005 Boehringer Ingelheim Investigational Site, Seoul

1235.5.46002 Boehringer Ingelheim Investigational Site, Gothenburg

1235.5.46003 Boehringer Ingelheim Investigational Site, Gothenburg

1235.5.46005 Boehringer Ingelheim Investigational Site, Luleå

1235.5.46004 Boehringer Ingelheim Investigational Site, Rättvik

1235.5.46001 Boehringer Ingelheim Investigational Site, Stockholm

1235.5.88605 Boehringer Ingelheim Investigational Site, Changhua

1235.5.88608 Boehringer Ingelheim Investigational Site, Hualien City

1235.5.88601 Boehringer Ingelheim Investigational Site, Kaohsiung City

1235.5.88603 Boehringer Ingelheim Investigational Site, Taichung

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00558428 - Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension | Biotech Hunter | Biotech Hunter